Joshua Richter, MD, and Roy Beveridge, MD, explain the role triplet regimens play in MM treatment and how physician decision-making has been impacted since the NCCN guidelines have expanded the list ...

Please provide your email address to receive an email when new articles are posted on . Three all-oral 9-month treatments for drug-resistant tuberculosis were found to be noninferior to standard ...

"Time has stood still" for many who've been on complex regimens for decades ...

Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according to new ...

In the search for shorter, effective, and safe regimens to treat fluoroquinolone-susceptible, rifampin-resistant tuberculosis (TB), three 9-month regimens incorporating newer and repurposed drugs ...

Panelists discuss how future AML treatment will likely involve sophisticated decisions about triplet combinations, optimal sequencing of targeted agents, and balancing efficacy with toxicity through ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

A phase I/II trial of high-dose methotrexate (HDMTX) followed by prophylactic glucarpidase in patients with impaired renal function and central nervous system lymphoma (CNSL). SOUNDTRACK-E: A phase ...

Violet Chihota is a member of the South African National TB Think Tank. Tuberculosis (TB) is a major cause of illness and death around the world. In 2019, 10 million people fell ill with TB and close ...

HRD status prediction in patients with advanced breast, prostate, ovarian and pancreatic cancers in a liquid biopsy assay. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...